Reliance (US:RELI)2026-03-10 20:15Financial Performance - Commission Income for 2025 was $12,430,959, a decrease of 12% from $14,054,361 in 2024, primarily due to portfolio realignments including the sale of Fortman Insurance Services, Employee Benefits Solutions, and U.S. Benefits Alliance[236]. - The company reported a net loss of $6,987,756 for the year ended December 31, 2025, a decrease of 23% compared to a net loss of $9,071,584 in 2024[239]. - AEBITDA for 2025 was $(1,596,628), reflecting a significant increase in losses of 397% compared to $(321,224) in 2024[239]. - Total operating expenses for 2025 were $21,443,955, a slight decrease of 1% from $21,749,680 in 2024, despite various fluctuations in specific expense categories[236]. Expenses - Commission Expense increased by 10% to $4,614,690 in 2025 from $4,189,599 in 2024, reflecting higher commissions associated with increased sales activity and market-driven increases in commission rates[236]. - Salaries and Wages rose significantly by 43% to $10,308,197 in 2025, up from $7,226,810 in 2024, largely due to non-cash share-based compensation[236]. - General and Administrative expenses increased by 16% to $4,910,823 in 2025, compared to $4,219,635 in 2024, driven by director non-cash equity awards[236]. Cash Flow - Cash balance as of December 31, 2025, was approximately $2,731,000, an increase from $1,798,000 in 2024, with restricted cash of $1,416,000[240]. - Net cash used in operating activities increased to $3,095,000 in 2025, up 23% from $2,515,000 in 2024[244]. - The company generated net cash flows from investing activities of approximately $5,328,000 in 2025, compared to a cash outflow of $83,000 in 2024[245]. - Net cash used in financing activities was approximately $1,300,000 in 2025, a reversal from net cash provided of $1,657,000 in 2024[246]. Strategic Initiatives - The Company completed a public offering on January 29, 2026, generating gross proceeds of approximately $2.0 million for working capital and strategic initiatives[230]. - The Company acquired approximately 8% of Enquantum Ltd. in February 2026, with potential to increase ownership to 51% through milestone-based investments[223]. - The Company adopted a digital asset treasury strategy in September 2025, holding digital assets subject to market price volatility as of December 31, 2025[225]. Compliance and Risks - The Company received a notification from Nasdaq on December 12, 2025, regarding non-compliance with the minimum bid price requirement, with a 180-day period to regain compliance[231]. - The company anticipates that inflation may materially impact pricing and operating expenses in future periods[241]. - The company had no off-balance sheet arrangements as defined in Regulation S-K[242]. Revenue Sources - The company’s revenue primarily consists of commissions from health insurance carriers, with additional revenue from contingent commissions based on performance targets[254][255]. Other - The company experienced a significant gain on the sale of business amounting to $3,182,917 in 2025[239].